Tailored Zwitterionic Hemicyanine Reporters for Early Diagnosis and Prognostic Assessment of Acute Renal Failure

Drug-induced renal failure (DIRF) poses a serious medical complication with high mortality risk. However, early diagnosis or prognosis of DIRF remain challenging, as current methods rely on detecting late-stage biomarkers. Herein we present a library of zwitterionic unimolecular hemicyanines (ZCs) available for constructing activatable reporters to detect DIRF since its initial stage. Zwitterionic properties of these probes are achieved through interspersedly integrating alkyl sulfonates and quaternary ammonium cations onto hemicyanine skeleton, which result in record low plasma protein binding (<5 %) and remarkable renal clearance efficiencies (≈96 %). An activatable reporter ZCRR is further developed by masking the optimal candidate ZC6 with a tetrapeptide specifically cleavable by caspase-8, an initiating indicator of apoptosis. In living mice with cisplatin-induced DIRF, systematically administered ZCRR efficiently accumulates in kidneys and responds to elevated caspase-8 for near-infrared fluorescence signals ‘turn-on’, enabling sensitive detection of intrarenal apoptosis 60 h earlier than clinical methods, and precise evaluation of apoptosis remediation effects by different medications on DIRF mice. As it's urinary excretable, ZCRR also allows for remote detection of DIRF and predicting renoprotective efficacy through in vitro optical urinalysis. This study thus presents unimolecular renal clearable scaffolds that are applicable to developing versatile activatable reporters for renal diseases management.     

SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF 3,6-DISUBSTITUTED S-TRIAZOLO[3,4-b]-1,3,4-THIADIAZOLES

A series of 3,6-disubstituted s-triazolo[3,4-b]-1,3,4-thiadiazoles have been synthesized,whosestructures were determined by elemental and spectral analyses;all the new compounds showed significantantibacterial activity.     

N-取代N′-苯基哌嗪类化合物与硫杂蒽酮体系光诱导电子转移引发聚合体系的研究

本工作对N-苯基-N'-乙基呱嗪作为酮/胺光引发体系中组分之一的作用机制进行了研究。发现该特殊的胺类化合物虽包括二甲基苯胺和三乙胺两个部分,但它和酮类相组合形成的光引发体系只有较低的尤引发速率。对上述现象进行了讨论,并通过加入酸类化合物使其中一个胺发生季胺盐化,用以改进光引发效率来进一步证实文中所讨论的机制。     

POLYMER-SUPPORTED RARE EARTH CATALYSTS FOR STYRENE POLYMERIZATION

The neodymium complex supported on styrene-maleic anhydride copolymer (SMA·Nd) has been prepared for the first time and found to be a highly effective catalyst for the polymerization of styrene. The SMA·Nd polymeric complex is characterized by IR and its catalytic activity, and the polymerization features have been investigated in comparison with that of the conventional Ziegler-Natta catalysts. When [Nd]=1×10~(-3) mol/L, [M]=5mol/L, Al/Nd=170(mol ratio) and CCl_4/Nd=50(mol ratio), the polymerization conversion of styrene gets to 51.6% in six hours, and the catalytic activity reaches 1852 gPS/gNd, which is much higher than that of conventional rare earth catalysts. The polymerization reaction has an induction period and shows some characteristics of chain polymerization. The polymerization rate is the first order with respect to the concentration of styrene monomer. Addition of FeCl_3 does not suppress the polymerization.     

钾离子选择电极及其在生物医学中的应用进展

钾离子选择电极的研究一直是一个非常活跃的题目,具有令人瞩目的发展。本文就其研制、测试法与应用方面的新进展进行评述。     

含DNA配体的VT吸附剂结构及其血液相容性研究

 本文以异氰尿酸三烯丙酯 TAIC)为交联剂,醋酸乙烯酯(VAC)为单体合成的共聚物(VT),经皂化和活化后,固载上DNA,即得含DNA配体的VT吸附剂。测定了各产物的物理性能,表面形态,红外光谱和血液相容性。实验结果表明:聚合物具有较大平均孔径,皂化后亲水性增强,随活化而使比表面积增大,孔分布趋于均匀,固载DNA的能力高,致使最后产物表面DNA覆盖致密程度高,考察其血液相容性良好,对血小板粘附率约为10％,对白细胞无破坏,每克吸附剂清除抗-DNA蛋白2小时可达60％以上。     

哌啶并[2,3-b]哌嗪类衍生物的设计、合成及其抗血小板聚集活性研究

以2,3-二氨基吡啶和2,3-丁二酮为起始原料,经环化、催化氢化和亲核取代反应合成了10个新型哌啶并[2,3-b]哌嗪类衍生物(3a~3j),其结构经¹H NMR、¹³C NMR和HR-MS确证。体外抗血小板聚集活性研究表明,化合物3d、3e、3g、3h和3j具有一定的抗血小板聚集作用,其中化合物3h(IC₅₀=1.24mmol/L)的活性显著优于母体化合物川芎嗪(IC₅₀=3.96mmol/L)和阳性药物阿司匹林(IC₅₀=2.41mmol/L)。     

碳酸钴中钴碳氮的测定与结构表征研究

碳酸钴由于受生产工艺的制约,生产的产品组分复杂,且市售碳酸钴产品的命名也存在多样性.采用X射线荧光光谱仪、电感耦合等离子体发射光谱仪、元素分析仪、X射线多功能粉末衍射仪和红外吸收光谱仪对某碳酸钴产品的成分进行测定和结构表征.结果表明:该碳酸钴产品钴、碳、氮的含量分别为46.53％、8.31％ 和1.48％,相对标准偏差...     

Nanotechnology for diagnosis and therapy of rheumatoid arthritis: Evolution towards theranostic approaches

Rheumatoid arthritis(RA),as a chronic autoimmune disease,damages the bone and cartilage of patients,and even leads to disability.Therefore,the diagnosis and treatment of RA is particularly important.However,due to the complexity of RA,it is difficult to make effective early diagnosis of RA,which is detrimental to RA treatment.Besides,long-term intake of anti-RA drugs can also cause damage to patients' organs.The emergence of nanotechnology provides the new train of thoughts for the diagnosis and treatment of RA.And the combination of diagnosis and therapy is an ideal method to solve the problem of disease management of RA patients.In this review,we summarize the mechanism and microenvironment of RA,discuss the commonly used diagnostic techniques and therapeutic drugs for RA,and review their advantages and disadvantages.New nanotherapy strategies such as drug-carrying nanoparticles,PTT,PDT are listed,and their applications in RA treatment are also summarized.In addition,multimodal imaging,combined therapy and responsive diagnosis and treatment are also summarized as important contents.At last,we also review typical nanocarriers that can be used in the integration of diagnosis and therapy,and discussed their potential applications in RA theranostics.